Resolution of Pudendal Neuralgia in Chronic Pelvic Pain Using a Novel Biologic Therapy

Active, not recruiting
Conditions
Registration Number
NCT06425575
Lead Sponsor
Thomas Jefferson University
Brief Summary

This goal of this study is to determine whether a novel biologic, i.e., an "amniotic suspension allograft" (ASA) will reduce pain and improve quality of life (QoL) in women stricken with chronic pelvic pain (CPP). The main questions it aims to answer are:

* Weather pain in the genitalia is reduced with treatment
...

Detailed Description

This is an observational study and is driven by the hypothesis that novel biologic, i.e., an "amniotic suspension allograft" (ASA) will reduce pain and improve quality of life in women stricken with chronic pelvic pain (CPP). This clinical trial is performed in a hospital-based practice at Thomas Jefferson University in which all patients over the age of 18 ...

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
50
Inclusion Criteria

All patients 18 years of age or older who present with chronic pelvic pain -

Read More
Exclusion Criteria
  1. Under 18 years of age
  2. Malignancy defined as terminal -
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall Pain and overall quality of lifeBetween 6 and 12 months after treatment

Pain in structures of the genitalia, rectum and pain during sexual activity

Secondary Outcome Measures
NameTimeMethod
Adverse eventsBetween 6 and 12 months after treatment

Zero pain relief

Bladder pain and urination frequencyBetween 6 and 12 months after treatment

Symptoms relating to interstitial cystitis

Trial Locations

Locations (1)

Thomas Jefferwson University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath